Related Experiment Video
Updated: Oct 12, 2025

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
Published on: July 4, 2007
The economics of stop-and-go epidemic control
1Institute for Theoretical Physics, Goethe University Frankfurt, Germany.
Abstract:
We analyse 'stop-and-go' containment policies that produce infection cycles as periods of tight lockdowns are followed by periods of falling infection rates. The subsequent relaxation of containment measures allows cases to increase again until another lockdown is imposed and the cycle repeats. The policies followed by several European countries during the Covid-19 pandemic seem to fit this pattern. We show that 'stop-and-go' should lead to lower medical costs than keeping infections at the midpoint between the highs and lows produced by 'stop-and-go'. Increasing the upper and reducing the lower limits of a stop-and-go policy by the same amount would lower the average medical load. But increasing the upper and lowering the lower limit while keeping the geometric average constant would have the opposite effect. We also show that with economic costs proportional to containment, any path that brings infections back to the original level (technically a closed cycle) has the same overall economic cost.
Related Concept Videos
Causality in Epidemiology
Steps in Outbreak Investigation
Statistical Methods for Analyzing Epidemiological Data
Introduction to Epidemiology
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...

